References
- Smit P, Oberholzer D, Hayden-Smith S, Koornhof HJ, Hilleman MR. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977; 238: 2613–6
- Koivula I, Sten M, Leinonen M, Makela PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 1997; 103: 281–90
- Conaty S, Watson L, Dinnes J, Waugh N. The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomized controlled trials. Vaccine 2004; 22: 3214–24
- Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta analyses. Eur J Epidemiol 2004; 19: 353–63
- Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30: 100–21
- Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanent Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187–95
- Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341–8.
- Facklam R, Washington JA. Streptococcus and related catalase-negative Gram-positive cocci. Manual of Clinical Microbiology5th edn, A Balows, WJ Hausler, Jr, KL Herrmann, HD Isenberg, HJ Shadomy. American Society for Microbiology, Washington, DC 1991; 238–57
- Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. Methods in Microbiology, T Bergan, JR Norris. Academic Press, Vol 12. New York 1978; 241–62
- Sorensen UB. Typing of pneumocci by using 12 pooled antisera. J Clin Microbiol 1993; 31: 2097–100
- Robbins JB, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun 1979; 26: 1116–22
- Sandgren A, Sjostrom K, Olsson-Liljequist B, Christensson B, Samuelsson A, Kronvall G, Henriques Normark B. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 2004; 189: 785–96
- Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190: 1203–11
- Burman LA, Trollfors B, Norrby R, Falsen E, Haidl S, Henrichsen J. Serotype distribution of Streptococcus pneumoniae strains isolated from blood and cerebrospinal fluid in Sweden. Scand J Infect Dis 1986; 18: 45–8
- Hedlund J, Svenson SB, Kalin M, Henrichsen J, Olsson-Liljequist B, Mollerberg G, Kallenius G. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis 1995; 21: 948–53
- Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 2002; 9: 358–65
- Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989–94. Epidemiol Infect 1996; 117: 411–6
- Pedersen MK, Hoiby EA, Froholm LO, Hasseltvedt V, Lermark G, Caugant DA. Systemic pneumococcal disease in Norway 1995–2001: capsular serotypes and antimicrobial resistance. Epidemiol Infect 2004; 132: 167–75
- Henriques Normark B, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis 2001; 184: 861–9
- Hedlund J, Sorberg M, Henriques Normark B, Kronvall G. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis 2003; 35: 452–8